Imatinib-associated tumour response in a dog with a non-resectable gastrointestinal stromal tumour harbouring a c-kit exon 11 deletion mutation

Veterinary Journal

Volumn 198, Issue 1, 2013, Pages 271-274

  Kobayashi, Masato ^a   Kuroki, Shiori ^a   Ito, Keita ^a   Yasuda, Akiko ^a   Sawada, Harumi ^a   Ono, Kenichiro ^a,b   Washizu, Tsukimi ^a   Bonkobara, Makoto ^a  

^a NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

^b Japan Animal Referral Medical Center   (Japan)

Author keywords

C kit exon 11; Deletion mutation; Dog; Gastrointestinal stromal tumour; Imatinib

Indexed keywords

ALANINE AMINOTRANSFERASE; GENOMIC DNA; IMATINIB;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL TISSUE; ARTICLE; CANCER REGRESSION; COMPUTER ASSISTED TOMOGRAPHY; DNA EXTRACTION; DOG; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; EXON; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE DELETION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MUTATIONAL ANALYSIS; NONHUMAN; ONCOGENE C KIT; TUMOR BIOPSY; TUMOR LOCALIZATION; TUMOR VOLUME;

CANIS FAMILIARIS;

C-KIT EXON 11; DELETION MUTATION; DOG; GASTROINTESTINAL STROMAL TUMOUR; IMATINIB;

ANIMALS; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; BENZAMIDES; DOG DISEASES; DOGS; EXONS; FEMALE; GASTROINTESTINAL STROMAL TUMORS; PIPERAZINES; POLYMERASE CHAIN REACTION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; SEQUENCE DELETION;

EID: 84887609102     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2013.05.035     Document Type: Article

References (10)

1. Corless C.L., Barnett C.M., Heinrich M.C. Gastrointestinal stromal tumours: Origin and molecular oncology. Nature Reviews Cancer 2011, 11:865-878.
2. Debiec-Rychter M., Dumez H., Judson I., Wasag B., Verweij J., Brown M., Dimitrijevic S., Sciot R., Stul M., Vranck H., et al. Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group. European Journal of Cancer 2004, 40:689-695.
3. Frost D., Lasota J., Miettinen M. Gastrointestinal stromal tumors and leiomyomas in the dog: A histopathologic, immunohistochemical, and molecular genetic study of 50 cases. Veterinary Pathology 2003, 40:42-54.
4. Gregory-Bryson E., Bartlett E., Kiupel M., Hayes S., Yuzbasiyan-Gurkan V. Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11. BMC Cancer 2010, 10:559.
5. Heinrich M.C., Corless C.L., Blanke C.D., Demetri G.D., Joensuu H., Roberts P.J., Eisenberg B.L., von Mehren M., Fletcher C.D., Sandau K., et al. Molecular correlates of imatinib resistance in gastrointestinal stromal tumors. Journal of Clinical Oncology 2006, 24:4764-4774.
6. Isotani M., Ishida N., Tominaga M., Tamura K., Yagihara H., Ochi S., Kato R., Kobayashi T., Fujita M., Fujino Y., et al. Effect of tyrosine kinase inhibition by imatinib mesylate on mast cell tumors in dogs. Journal of Veterinary Internal Medicine 2008, 22:985-988.
7. Letard S., Yang Y., Hanssens K., Palmérini F., Leventhal P.S., Guéry S., Moussy A., Kinet J.P., Hermine O., Dubreuil P. Gain-of-function mutations in the extracellular domain of KIT are common in canine mast cell tumors. Molecular Cancer Research 2008, 6:1137-1145.
8. Russell K.N., Mehler S.J., Skorupski K.A., Baez J.L., Shofer F.S., Goldschmidt M.H. Clinical and immunohistochemical differentiation of gastrointestinal stromal tumors from leiomyosarcomas in dogs: 42 cases (1990-2003). Journal of American Veterinary Medical Association 2007, 230:1329-1333.
9. Sarlomo-Rikala M., Kovatich A.J., Barusevicius A., Miettinen M. CD117: A sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Modern Pathology 1998, 11:728-734.
10. Wozniak A., Rutkowski P., Piskorz A., Ciwoniuk M., Osuch C., Bylina E., Sygut J., Chosia M., Rys J., Urbanczyk K., et al. Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumours (GIST): Polish Clinical GIST Registry experience. Annals of Oncology 2012, 23:353-360.